瑞可達(688800.SH):前三季度已簽訂單同比增長94%、擬籌建西安研發中心
格隆匯10月20日丨瑞可達(688800.SH)公佈,2022年前三季度已簽訂單157392.76萬元人民幣,同比增長94%。本期訂單變化的主要原因如下:
公司2022年圍繞既定發展戰略,利用自身產品、技術、服務等優勢,聚焦價值客户需求,積極應對疫情影響,實現公司穩步增長,前三季度已簽訂新能源汽車及儲能訂單金額合計135955.66萬元,簽訂通信訂單11141.92萬元,簽訂其他訂單10295.18萬元。
為貫徹實施公司人才戰略,持續加大研發投入,招募國內各重點城市高端研發人才,加快產品迭代創新,並配合主要客户實現就近參與研發的要求,公司擬在西安市籌建研發中心,上述事宜正在籌劃中,公司會嚴格按照相關法律法規要求及時履行信息披露、內部審議等相關程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.